[Long QT syndrome due to olanzapine administration].
A case of a 53 year old female with olanzapine-induced QT interval prolongation and ventricular fibrillation is described. The relationship between neuroleptic drugs and the risk of sudden cardiac death is discussed.
Janion
Marianna
M
Swietokrzyskie Centrum Kardiologii, ul. Grunwaldzka 45, 25-736 Kielce. mjanion@interia.pl
Dudek
Aneta
A
Sielski
Janusz
J
Janion-Sadowska
Agnieszka
A
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D008875:Middle Aged; D000077152:Olanzapine; D011188:Potassium / Q000008:administration & dosage; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000175:diagnosis; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D011188:Potassium